A look at the pharmaceutical company's earnings and performance of its cancer drug, with CNBC's Mike Huckman

Swiss drug giant Roche makes a play for all of Genentech and a look at earnings for the pharma sector, with CNBC's Mike Huckman

14

Drugmaker Roche offers to acquire all outstanding Genentech shares, with Franz Humer, Roche chairman

Genentech earnings and analysis, with CNBC's Mike Huckman

...company ...uy the roughly 44% of U.S. biotech firm Genentech it doesn't already own for nearly $44 billion. WSJ's Jacob Goldstein says this is no ordinary offer and tells us what we can expect. ...